Evaluation of a screening-based onco-geriatric internvention in vulnerable older patients with cancer in an outpatient treatment setting. A randomized single-center study.

Evaluation of a screening-based onco-geriatric internvention in vulnerable older patients with cancer in an outpatient treatment setting. A randomized single-center study. - onco-geriatric intervention in vulnerable cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00024974

Enrollment

300

Registered

2022-06-20

Start date

2022-04-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C79 C50

Interventions

Group 1: multidisciplinary geriatric interventions: physical therapy, nutrional support, psycho-oncological support, polypharmacy, treatment plan defintion, etc.) Group 2: Standard treatment

Eligibility

Sex/Gender

All

Age

70 Years to No maximum

Inclusion criteria

Inclusion criteria: written informed consent age >70 Years outpatient treatment for cancer systemic treatment willing to adhere to supportive care recommendations

Exclusion criteria

Exclusion criteria: Lack of understanding the German language. Dementia, presence of guardianship, multiple malignancies are explicitly no exclusion criteria

Design outcomes

Primary

Measure	Time frame
proof of efficacy of a comprehensive geraitzric assessment and focussed intervention on T2 (12 weeks) independence (IADL) and QOL	—

Secondary

Measure	Time frame
Description of the T2 variable CTCAE >/= 3 and presence of palliative care documents (advance directive, advanced care plan, emergency plan)	—

Countries

Germany

Contacts

Public ContactBarbara Deschler-Baier

CCC Mainfranken Uniklinik Würzburg

deschler_b@ukw.de+4993120135060

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026